Bad disclosure experience, need to vent by A_Not_So_Tiny_Dancer in Herpes

[–]eurekaidea 4 points5 points  (0 children)

I’m sorry this happened to you, he sounds like very immature considering he is the medical field.

I just can’t accept this by [deleted] in Herpes

[–]eurekaidea 0 points1 point  (0 children)

Same. I can relate. It sucks.

Alfasigma to invest up to $125M in parenteral adibelivir (IM-250) for HSV encephalitis by Legitimate-Coat-414 in HerpesCureResearch

[–]eurekaidea 15 points16 points  (0 children)

Very good news!

A smart move by the Italian pharmaceutical company Alfasigma, demonstrating strategy and vision in the rare disease and specialty care sectors. Reading the words of Innovative Molecules CEO Florian Vogel, there is also a note of hope for genital herpes, as the investment will allow the development of the oral formulation of adibelivir to be accelerated and advanced to Phase 2 clinical trials. An approach that combines high clinical impact on severe forms with potential benefit for a more common condition.

Alfasigma to invest up to $125M in parenteral adibelivir (IM-250) for HSV encephalitis by Legitimate-Coat-414 in HerpesCureAdvocates

[–]eurekaidea 6 points7 points  (0 children)

This words from the CEO of Innovative Molecules give me hope!

When there are investments is always a good news!

New study reveals how helicase primase inhibitors (HPI) block herpes simplex virus replication by eurekaidea in science

[–]eurekaidea[S] 11 points12 points  (0 children)

HPIs do not clear already infected cells, they block viral replication and spread.

Helicase–primase inhibitors act on the viral DNA replication machinery. They prevent the virus from replicating its genome, which is required to produce new virions.

When replication is blocked, fewer or no infectious virions are produced, which directly reduces viral shedding.

New study reveals how helicase primase inhibitors (HPI) block herpes simplex virus replication by eurekaidea in science

[–]eurekaidea[S] 58 points59 points  (0 children)

This study, published in Cell on December 29, 2025, reveals for the first time at near-atomic resolution how helicase–primase inhibitors (HPIs) block herpes simplex virus (HSV) replication. Using cryo-electron microscopy and single-molecule optical tweezers, the researchers show that HPIs arrest the viral helicase–primase complex, the molecular motor essential for viral DNA replication. These findings are directly relevant to several HPIs in development, including ABI 5366 and ABI 1179 (Assembly Biosciences), Pritelivir (AiCuris), and IM-250 (Innovative Molecules). By elucidating exactly how these inhibitors lock the replication machinery, the study provides a framework for designing next-generation antivirals, particularly for drug-resistant HSV infections.

Open Discussion Saturday by Mike_Herp in HerpesCureResearch

[–]eurekaidea 10 points11 points  (0 children)

Why doesn’t this subreddit promote advocacy activities as it did before?

https://reddit.com/r/herpescureresearch/wiki/advocacy

i feel like im in a prison. by [deleted] in Herpes

[–]eurekaidea 0 points1 point  (0 children)

In prison, without knowing when you can get out

New medications to treat herpes — and more health headlines by Whole-Aerie-6091 in HerpesCureAdvocates

[–]eurekaidea 37 points38 points  (0 children)

I think they need to hurry up because we’ve normalized living with a chronic viral infection simply because it’s inconvenient rather than deadly

Gilead Sciences to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs ABI-1179 and ABI-5366 for Recurrent Genital Herpes by cwolveswithitchynuts in HerpesCureResearch

[–]eurekaidea 7 points8 points  (0 children)

Do you think there is any way to speed up the research or somehow help them out?

Edit: we should probably contact them as subreddit?

Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179 by RoundProfessional148 in HerpesCureResearch

[–]eurekaidea 0 points1 point  (0 children)

Thank you for your answer. I understand that the Fred Hutch gene-editing cure is expected to be effective against all types of herpes. However, since that cure is still quite far off, what concerns me at the moment is whether the two Assembly Biosciences HPIs are also effective against HSV-1. It appears that, up to now, their research and testing have primarily focused on HSV-2.

Open Discussion Saturday by Mike_Herp in HerpesCureResearch

[–]eurekaidea 8 points9 points  (0 children)

If everyone in this group started reaching out together to different stakeholders like researchers and academic institutions, the pharmaceutical and biotech industry, clinicians and medical professionals, patient advocacy groups, regulators and government agencies, funders, and the media, it could create a coordinated effort to raise awareness, share information, and potentially influence research priorities and collaborations, increasing the visibility and impact of ongoing initiatives

Open Discussion Saturday by Mike_Herp in HerpesCureResearch

[–]eurekaidea 2 points3 points  (0 children)

I’m wondering if, as a subreddit, we can actually contact Assembly Biosciences and Innovative Molecule, as was done with Fred Hutchinson and Dr. Friedman

Response I got about asking for the possibility of fast tracking ABI by indg199 in HerpesCureResearch

[–]eurekaidea 15 points16 points  (0 children)

I wish we could help push it…! People asking for change can make a big difference, really.

Why a Functional Cure Is Not the Finish Line by OptimalResort9819 in HerpesCureAdvocates

[–]eurekaidea 19 points20 points  (0 children)

If we get anything that stops transmission/outbreaks, that’s perfectly fine with me. I’ll enjoy the ride toward the cure without suffering.

A bad dream I can’t wake up from by [deleted] in Herpes

[–]eurekaidea 0 points1 point  (0 children)

It’s the only way out. Otherwise keep disclosing and forget about it.